Preoperative Downstaging of Extraperitoneal T3 Rectal Cancer: XELOXRT Versus XELACRT. A Multicenter, Phase III Study

NCT01653301 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

616

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer

Interventions

DRUG: XELAC RT
DRUG: XELOX RT

Sponsor

Catholic University of the Sacred Heart